Titlebook: Nanostructured Materials and Their Applications; Stergios Logothetidis Book 2012 Springer-Verlag Berlin Heidelberg 2012 carbon nanomateria

JOLT

書目名稱Nanostructured Materials and Their Applications影響因子(影響力)




書目名稱Nanostructured Materials and Their Applications影響因子(影響力)學(xué)科排名




書目名稱Nanostructured Materials and Their Applications網(wǎng)絡(luò)公開度




書目名稱Nanostructured Materials and Their Applications網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nanostructured Materials and Their Applications被引頻次




書目名稱Nanostructured Materials and Their Applications被引頻次學(xué)科排名




書目名稱Nanostructured Materials and Their Applications年度引用




書目名稱Nanostructured Materials and Their Applications年度引用學(xué)科排名




書目名稱Nanostructured Materials and Their Applications讀者反饋




書目名稱Nanostructured Materials and Their Applications讀者反饋學(xué)科排名

無脊椎

S. Logothetidisoting sample preparation methods for drug products at all st.This book is intended to serve as a resource for analysts in developing and troubleshooting sample preparation methods.? These are critical activities in providing accurate and reliable data throughout the lifecycle of a drug product.? .Th

GLIDE

Kyriakos Porfyrakis,Jamie H. Warneroting sample preparation methods for drug products at all st.This book is intended to serve as a resource for analysts in developing and troubleshooting sample preparation methods.? These are critical activities in providing accurate and reliable data throughout the lifecycle of a drug product.? .Th

ingenue

Inferior

Glucose

Argyrios C. Varonidesoting sample preparation methods for drug products at all st.This book is intended to serve as a resource for analysts in developing and troubleshooting sample preparation methods.? These are critical activities in providing accurate and reliable data throughout the lifecycle of a drug product.? .Th

星球的光亮度

遺留之物

A. Laskarakis,S. Logothetidiss in providing accurate and reliable data throughout the lifecycle of a drug product.? .This book is divided into four parts:.?????????? Part One covers dosage form and diluent properties that impact sample preparation of pharmaceutical dosage forms and the importance of sampling considerations in g

正面

Dietmar Keiper,Nico Meyer,Michael Heukenapture a more complete characterization of the intervention effects and provide more informative intervention comparisons. For these reasons, use of more than one primary endpoint has become a common design feature in clinical trials for disease areas such as oncology, infectious disease, and cardio

CODE